The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 11,135,564 | 24,850,623 | SH | SOLE | 24,850,623 | 0 | 0 | |||
| CYTOKINETICS INC | COM NEW | 23282W605 | 24,114,000 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | |||
| INNOVIVA INC | COM | 45781M101 | 51,054,479 | 2,816,022 | SH | SOLE | 2,816,022 | 0 | 0 | |||
| IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 24,093,300 | 16,390,000 | SH | SOLE | 16,390,000 | 0 | 0 | |||
| LANTHEUS HLDGS INC | COM | 516544103 | 9,760,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
| NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 34,188,230 | 309,116 | SH | SOLE | 309,116 | 0 | 0 | |||
| VOR BIOPHARMA INC | COM | 929033108 | 364,501 | 508,016 | SH | SOLE | 508,016 | 0 | 0 | |||